SIU 2017: Lateral Bladder Neck Dissection Technique and Triple-Layer Posterior Bladder Wall Reconstruction Lead to Early Removal of Foley Catheter and Improved Urinary Continence after Robotic-Assisted Radical Prostatectomy
Lisbon, Portugal (UroToday.com) Recovery of urinary continence is an important functional outcome following prostatectomy, including robotic prostatectomy. Various techniques have been attempted to help improve return of urinary continence, including intra-operative vas deferens sling, rocco stitch, etc. Very little has been shown to improve continence except urethral length and sparing of the levator muscles.
SIU 2017: Prospective Comparative Analysis of Oncologic and Functional Outcomes Between Focal Therapy and Robotic Radical Prostatectomy
Lisbon, Portugal (UroToday.com) Focal therapy for localized prostate cancer has had increasing recognition and acceptance. However, while short term outcomes appear adequate, long-term data is still pending. By reducing impact on functional quality of life in men with low-volume disease, they help address a patient population often stuck between active surveillance and radical treatment. The ideal patient is not yet clear though, nor is the appropriate follow-up and triggers for reintervention/radical therapy.
SIU 2017: Conditional Probability of Biochemical Recurrence-Free Survival and Cancer-Specific Mortality after Radical Prostatectomy at Long Term Follow-Up
Lisbon, Portugal (UroToday.com) When it comes to counseling patients, we are often struggling to provide patients with updated survival benefits as they move further out from initial intervention. While our initial survival data is well established, as patients are further removed from their treatment, their survival estimates change – often for the better.
SIU 2017: Discerning Predictors for Gender Differences in Survival Outcomes for Patients Treated for Bladder Cancer
Lisbon, Portugal (UroToday.com) Radical cystectomy (RC) is an underutilized treatment option for those with refractory non-muscle invasive and muscle-invasive bladder cancer; however, use of RC may differ according to gender. The authors wanted to discern receipt and timing of RC as well as survival outcomes according to gender.
SIU 2017: Use of Concurrent Chemotherapy with Radiation Therapy for Bladder Cancer in the United States: A Quality of Care Comparative Effectiveness Study
Lisbon, Portugal (UroToday.com) For older bladder cancer patients, there is limited evidence of the efficacy of concurrent chemotherapy with radiation therapy in the community setting. The authors attempted to assess the relationship between concurrent chemotherapy use and survival in a large, population-based cohort of older patients with muscle-invasive bladder cancer.
SIU 2017: Identification of Factors Associated with Delayed Haematuria Assessment
Lisbon, Portugal (UroToday.com) While most causes of hematuria are benign or idiopathic, hematuria is the commonest presenting symptom of bladder cancer. A likely benign etiology may lead to delayed or inadequate hematuria assessment, subsequently affecting bladder cancer management in some patients. The authors attempted to identify factors that impact on the timeliness and adequacy of hematuria evaluation.
SIU 2017: Predictors of Bladder Cancer Following Hematuria
Lisbon, Portugal (UroToday.com) Bladder cancer typically presents with painless hematuria, although only a minority will have underlying malignancy. The authors aimed to identify predictors of bladder cancer diagnosis following evaluation of hematuria, in order to formulate an appropriate approach to hematuria in Australia.